Segment disclosures

Company overview

오름테라퓨틱

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3024105273 KRW20260814Open filing evidence
2026-01-01 – 2026-06-3024105273 KRW20260814Open filing evidence
2026-01-01 – 2026-03-310 KRW20260515Open filing evidence
2025-01-01 – 2025-12-3123564233 KRW20260319Open filing evidence
2025-07-01 – 2025-09-3015889734 KRW20251114Open filing evidence
2025-01-01 – 2025-09-3023006057 KRW20251114Open filing evidence
2025-04-01 – 2025-06-304162791 KRW20260814Open filing evidence
2025-01-01 – 2025-06-307116323 KRW20260814Open filing evidence
2025-01-01 – 2025-03-312953532 KRW20260515Open filing evidence
2024-01-01 – 2024-12-3120905620577 KRW20260319Open filing evidence
2024-07-01 – 2024-09-3020871505754 KRW20251114Open filing evidence
2024-01-01 – 2024-09-3020903144730 KRW20251114Open filing evidence
2024-04-01 – 2024-06-3016192863 KRW20250814Open filing evidence
2024-01-01 – 2024-06-3031638976 KRW20250814Open filing evidence
2024-01-01 – 2024-03-3115446113 KRW20250515Open filing evidence
2023-01-01 – 2023-12-31135417607412 KRW20260319Open filing evidence
2022-01-01 – 2022-12-3175919295 KRW20250320Open filing evidence